132 filings
Page 3 of 7
8-K
0s5v49anu jhyp5i1k95
21 Aug 08
Lotus Pharmaceuticals Announces Second Quarter 2008 Results
12:00am
424B3
u90o rnt47k
25 Jul 08
Prospectus supplement
12:00am
EFFECT
sqtvrdoyndvqxgmuue
25 Jul 08
Notice of effectiveness
12:00am
CORRESP
gdz2ipameyn0c2uz62c7
23 Jul 08
Correspondence with SEC
12:00am
8-K
8uw8k wwqaoeftb4vb
17 Jul 08
Entry into a Material Definitive Agreement
12:00am
UPLOAD
bkf2xe lx
2 Jul 08
Letter from SEC
12:00am
UPLOAD
q50l80zgdz5 hz
23 Jun 08
Letter from SEC
12:00am
S-1/A
kdxdl9dyf0cscv5pysb
20 Jun 08
IPO registration (amended)
12:00am
EFFECT
guluv06tf f4l4rgd
17 Jun 08
Notice of effectiveness
12:00am
POS AM
780sxu5bk2m
16 Jun 08
Prospectus update (post-effective amendment)
12:00am
UPLOAD
fngrmisd rni9
3 Jun 08
Letter from SEC
12:00am
8-K
ui6 q8xecw9ru
30 May 08
Lotus Pharmaceuticals Inc Q1 Earnings Conference Call
12:00am
8-K
1oc10uaxh86
30 May 08
Lotus Pharmaceuticals, Inc. Obtains Patent and Exclusive Production Rights to Laevo-Bambutero Asthma Treatment
12:00am
8-K
ktgllxog823ny
22 May 08
Results of Operations and Financial Condition
12:00am
10-Q
6equn 3tnor
20 May 08
Quarterly report
12:00am
NT 10-Q
jx2tfbss
16 May 08
Notice of late quarterly filing
12:00am
CORRESP
4dh6f3awhcxa0o7u
13 May 08
Correspondence with SEC
12:00am
S-1
2qb 2h57f
13 May 08
IPO registration
12:00am